In SCLC, subtypes driven by ASCL1, NEUROD1, and POU2F3 meet these criteria, as each defines a transcriptionally and epigenetically stable state linked to neuroendocrine identity, cell lineage, and drug response. Here, ASCL1 is linked to small cell lung carcinoma.